Elena Olegovna Popova

Ms. Elena Olegovna Popova

World-Class Research Center “Digital Biodesign and Personalized Healthcare”, I. M. Sechenov First Moscow State Medical University, Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2024 in Cells
Verified
Journal Article
Open access
PDF file
STSergey Tkachev
Sergey Tkachev
NCNatalia Chepelova
Natalia Chepelova
GGGevorg Galechyan
Gevorg Galechyan
BEBoris Ershov
Boris Ershov
DGDanila Golub
Danila Golub
PTPeter S. Timashev
Peter S. Timashev
Among all of the materials used in tissue engineering in order to develop bioequivalents, collagen shows to be the most promising due to its superb biocompatibility and biodegradability, thus becoming one of the most widely used materials for scaffold production. However, current imaging techniques of the cells within collagen scaffolds have several limitations, which lead to an urgent need for novel methods of visualization. In this work, we have obtained groups of collagen scaffolds and selected the contrasting agents in order to study pores and patterns of cell growth in a non-disruptive manner via X-ray computed microtomography (micro-CT). After the comparison of multiple contrast agents, a 3% aqueous phosphotungstic acid solution in distilled water was identified as the most effective amongst the media, requiring 24 h of incubation. The differences in intensity values between collagen fibers, pores, and masses of cells allow for the accurate segmentation needed for further analysis. Moreover, the presented protocol allows visualization of porous collagen scaffolds under aqueous conditions, which is crucial for the multimodal study of the native structure of samples.

28 March 2025 in Cancers
Verified
Journal Article
Open access
PDF file
STSergey Tkachev
Sergey Tkachev
VBVladimir Brosalov
Vladimir Brosalov
OKOleg Ivanovich Kit
Oleg Ivanovich Kit
AMAlexey Maksimov
Alexey Maksimov
AGAnna Goncharova
Anna Goncharova
PTPeter S. Timashev
Peter S. Timashev
Invasion and metastasis are well-known hallmarks of cancer, with metastatic disease accounting for 60% to 90% of cancer-related deaths

5 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EPElena Olegovna Popova
Elena Olegovna Popova
STSergey Tkachev
Sergey Tkachev
ASArtur Shapoval
Artur Shapoval
Anastasia KarpenkoAnastasia Karpenko
Anastasia Karpenko
YLYuliya Lee
Yuliya Lee
PTPeter S. Timashev
Peter S. Timashev
Despite the recent advances in minimally invasive surgery, kidney stones still pose a significant clinical challenge due to their high recurrence rate of 50% in 5–10 years after the first stone episode. Using the methods of geosciences and biology, the GeoBioMed approach treats kidney stones as biogenic minerals, offering a novel perspective on their formation and dissolution processes. In this review, we discuss kidney stones’ structural and mechanical properties as emerging biomarkers of urolithiasis, emphasizing the importance of a comprehensive stone analysis in developing personalized treatment strategies. By focusing on unexplored properties like crystalline architecture, porosity, permeability, cleavage, and fracture, alongside the conventionally used composition and morphology, we show how these stone characteristics influence the treatment efficacy and the disease recurrence. This review also highlights the potential of advanced imaging techniques to uncover novel biomarkers, contributing to a deeper understanding of stone pathogenesis. We discuss how the interdisciplinary collaboration within the GeoBioMed approach aims to enhance the diagnostic accuracy, improve the treatment outcomes, and reduce the recurrence of urolithiasis.

19 October 2022 in Cancers
Verified
Journal Article
Open access
PDF file
EPElena Olegovna Popova
Elena Olegovna Popova
STSergey Tkachev
Sergey Tkachev
IRIgor Reshetov
Igor Reshetov
PTPeter S. Timashev
Peter S. Timashev
IUIlya Ulasov
Ilya Ulasov
Sarcomas are a leading cause of cancer death in individuals younger than 20 years of age and represent the largest group of rare solid tumors. To date, more than 100 morphological subtypes of sarcomas have been described, among which epidemiology, clinical features, management, and prognosis differ significantly. Delays and errors in the diagnosis of sarcomas limit the number of effective therapeutic modalities and catastrophically worsen the prognosis. Therefore, the development of an algorithm for the early accurate diagnosis of sarcomas seems to be as important as the development of novel therapeutic advances. This literature review aims to summarize the results of recent investigations regarding the imaging of sarcoma progression based on the use of X-ray computed tomography (CT) in preclinical studies and in current clinical practice through the lens of cancer hallmarks. We attempted to summarize the main CT imaging features of soft-tissue and bone sarcomas. We noted the development of new molecular markers with high specificity to antibodies and chemokines, which are expressed in particular sarcoma subtypes to reach tumor type-specific imaging. We demonstrate the possibility of the use of X-ray computed microtomography (micro-CT) for non-destructive 3D visualization of solid tumors by increasing the visibility of soft tissues with X-ray scattering agents. Based on the results of recent studies, we hypothesize that micro-CT enables the visualization of neovascularization and stroma formation in sarcomas at high-resolution in vivo and ex vivo, including the novel techniques of whole-block and whole-tissue imaging. Finding correlations between CT, PET/CT, and micro-CT imaging features, the results of the histopathological specimen examination and clinical outcomes may significantly increase the accuracy of soft-tissue and bone tumor diagnostics, which leads to the initiation of appropriate histotype-specific management in a timely manner and, consequently, to improved outcomes.

5 September 2024 in Urology Herald
Verified
Journal Article
Open access
PDF file
EPElena Olegovna Popova
Elena Olegovna Popova
STSergey Tkachev
Sergey Tkachev
Anastasia KarpenkoAnastasia Karpenko
Anastasia Karpenko
YLYu. A. Lee
Yu. A. Lee
PCPavel Chislov
Pavel Chislov
PTPeter S. Timashev
Peter S. Timashev
Despite advances in minimally invasive surgery, urolithiasis still recurs within the first five years after the first episode in more than 50% of patients. Researchers continue to search for new crystallisation inhibitors, metaphylaxis strategies and laser sources for stone destruction. Therefore, to achieve these goals, it is necessary to study kidney stones not only as the result of an isolated process of pathological biomineralisation in the human body, but also as a biogenic mineral or rock that obeys universal patterns and has certain properties. Consequently, kidney stones need to be studied using methods that are widely used in the geological sciences for the study of minerals, such as computed microtomography and petrological analysis. In this review, the properties of kidney stones studied using various research methods used in geosciences are discussed. These properties are also considered as new biomarkers of urolithiasis. This review discusses how new data from multimodal stone analysis can be used to develop personalised metaphylaxis and treatment strategies for all types of urolithiasis, including the most common idiopathic calcium-oxalate urolithiasis.